The opioid crisis has touched nearly every demographic in our society. One area that doesn’t get enough attention is the toll ...

This week, the FDA will decide whether to approve Vertex Pharmaceuticals' non-opioid painkiller. Vertex believes pain could ...

Having shown last week that its opioid alternative can reduce post-surgery pain, Tris Pharma is back with another slice of ...

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), with its substantial $114.5 billion market capitalization, continues to dominate the cystic fibrosis (CF) treatment market while advancing a ...

Germany's medical cannabis market in 2024 saw record affordability, 1,000% prescription growth, and digital access ...

At the time, MDMA, also known as the party drug ecstasy, had been outlawed in Australia since 1987, despite research ...

Kashiv Biosciences, LLC, a global leader in biopharmaceutical innovation, today announced that their abatacept biosimilar candidate, KSHB002, has successfully met the primary endpoints in its Phase 1 ...

The FinOps Foundation, a part of the Linux Foundation's non-profit technology consortium focusing on advancing the people and practice of FinOps, announced today that Oracle has upgraded to Premier ...

OncoZenge AB (publ) (“OncoZenge” or the “Company”) announces that the Company has entered into an investment agreement (the “Investment Agreement”)whereby the Chinese investor Sichuan Yangtian ...